Identifier financieringsorganisatie: FP7-KBBE-2012-6-singlestage (Other contract id)
Acroniem: PHARMASEA
Periode: Oktober 2012 tot September 2016
Status: Afgelopen
|
|
- KU Leuven (KULeuven), meer, coördinator
- BioBridge, meer, partner
- University of Aberdeen, meer, partner
- Aquapharm Biodiscovery Ltd, meer, partner
- University of Tromso, meer, partner
- eCOAST, meer, partner
- University College Cork (UCC), meer, partner
- Stazione Zoologica 'Anton Dohrn' of Naples (SZN), meer, partner
- Italian National Research Council (CNR), meer, partner
- University of Santiago de Compostela (USC), meer, partner
- Technical University of Denmark (DTU), meer, partner
- IUCN Headquarters - International Union for Conservation of Nature (IUCN), meer, partner
- University of Waikato, meer, partner
- Asociacion Instituto Nacional de Biodiversidad, meer, partner
- Instituto de Dinámica Celular y Biotecnología, meer, partner
- University of the Western Cape, meer, partner
- Chinese Academy of Sciences; Institute of Microbiology, meer, partner
- Wuhan University, meer, partner
- Advanced Chemistry Development Uk Ltd, meer, partner
- Deep Tek Ltd, meer, partner
- c-Lecta, meer, partner
- Royal Society of Chemistry, meer, partner
- BioCom, meer, partner
- Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía (MEDINA), meer, partner
|
| The PharmaSea project focuses on obstacles in marine biodiscovery research, development and commercialization and brings together a broad interdisciplinary team of academic and industry researchers and specialists to address and overcome these. The partners are ideally placed to demonstrate how to widen the bottlenecks and increase the flow of ideas and products derived from the marine microbiome towards a greater number of successes in a larger number of application areas. |
|
